SLN mapping has emerged as a viable compromise between a comprehensive lymphadenectomy and no lymph node sampling in the surgical staging of these patients, and may lead to reduced morbidity risks. In this review, we present the currently available data in this area of research, as well as our experience with SLN mapping.
Keyphrases
- sentinel lymph node
- lymph node
- neoadjuvant chemotherapy
- high resolution
- early stage
- end stage renal disease
- high density
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- electronic health record
- squamous cell carcinoma
- risk assessment
- patient reported outcomes
- deep learning
- artificial intelligence
- robot assisted